Induction of p38- and gC1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble hepatitis C core protein

Respiratory Research

Volumn 6, Issue , 2005, Pages

  Moorman, Jonathan P ^a,b   Fitzgerald, S Matthew ^a   Prayther, Deborah C ^a   Lee, Steven A ^a   Chi, David S ^a   Krishnaswamy, Guha ^a,b  

^a East Tennessee State University   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN; C1QBP PROTEIN, HUMAN; CARRIER PROTEIN; MITOCHONDRIAL PROTEIN; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTRACELLULAR SPACE; LUNG DISEASE; LUNG FIBROBLAST; LUNG FUNCTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS NUCLEOCAPSID; CELL CULTURE; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; IMMUNOLOGY; SOLUBILITY;

CARRIER PROTEINS; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; MITOCHONDRIAL PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SOLUBILITY; VIRAL CORE PROTEINS;

EID: 26244461035     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-6-105     Document Type: Article

References (39)

1. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, and et al.: The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. New England Journal of Medicine 1992, 327:1899-905.
2. Moorman JP: Challenges in the HIV patient co-infected with hepatitis C. Curr Hep Rep 2002, 1:9-15.
3. Moorman J, Joo M, and Hahn Y: Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence. Arch Immunol Ther Exp (Warsz) 2001, 49:189-194.
4. Kanazawa H, Hirata K, and Yoshikawa J: Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients. Chest 2003, 123:596-9.
5. Kanazawa Hand Yoshikawa J: Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study. Am J Med 2004, 116:749-52.
6. Manganelli P, Salaffi F, and Pesci A: [Hepatitis C virus and pulmonary fibrosis]. Recenti Prog Med 2002, 93:322-6.
7. Idilman R, Cetinkaya H, Savas I, Aslan N, Sak SD, Bastemir M, Sarioglu M, Soykan I, Bozdayi M, Colantoni A, Aydintug O, Bahar K, Uzunalimoglu O, Van Thiel DH, Numanoglu N, and Dokmeci A: Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C. J Med Virol 2002, 66:34-9.
8. Kaplanski G, Farnarier C, Payan MJ, Bongrand P, and Durand JM: Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis. Dig Dis Sci 1997, 42:2277-84.
9. Polyak SJ, Khabar KS, Rezeiq M, and Gretch DR: Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 2001, 75:6209-11.
10. Shimoda K, Begum NA, Shibuta K, Mori M, Bonkovsky HL, Banner BF, and Barnard GF: Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology 1998, 28:108-15.
11. Mahmood S, Sho M, Yasuhara Y, Kawanaka M, Niiyama G, Togawa K, Ito T, Takahashi N, Kinoshita M, and Yamada G: Clinical significance of intrahepatic interleukin-8 in chronic hepatitis C patients. Hepatol Res 2002, 24:413-419.
12. Mukaida N: Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 2003, 284:L566-77.
13. Hoffmann E, Dittrich-Breiholz O, Holtmann H, and Kracht M: Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002, 72:847-55.
14. Moorman JP, Prayther D, McVay D, Hahn YS, and Hahn CS: The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization. Virology 2003, 312:320-9.
15. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, and Hahn YS: Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 2000, 106:1239-49.
16. Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, and Lai MM: Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. Journal of Virology 1998, 72:3691-7.
17. Masalova OV, Atanadze SN, Samokhvalov EI, Petrakova NV, Kalinina TI, Smirnov VD, Khudyakov YE, Fields HA, and Kushch AA: Detection of hepatitis C virus core protein circulating within different virus particle populations. J Med Virol 1998, 55:1-6.
18. Kato N, Yoshida H, Kioko Ono-Nita S, Kato J, Goto T, Otsuka M, Lan K, Matsushima K, Shiratori Y, and Omata M: Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 2000, 32:405-12.
19. Yao ZQ, Eisen-Vandervelde A, Waggoner SN, Cale EM, and Hahn YS: Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. J Virol 2004, 78:6409-19.
20. Fitzgerald SM, Lee SA, Hall HK, Chi DS, and Krishnaswamy G: Human lung fibroblasts express interleukin-6 in response to signaling after mast cell contact. Am J Respir Cell Mol Biol 2004, 30:585-93.
21. Krishnaswamy G, Smith JK, Mukkamala R, Hall K, Joyner W, Yerra L, and Chi DS: Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids. Microvasc Res 1998, 55:189-200.
22. Yao ZQ, Eisen-Vandervelde A, Ray S, and Hahn YS: HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1. Virology 2003, 314:271-82.
23. Yao ZQ, Nguyen DT, Hiotellis AI, and Hahn YS: Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J Immunol 2001, 167:5264-72.
24. You LR, Chen CM, and Lee YH: Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol 1999, 73:1672-81.
25. Park KJ, Choi SH, Koh MS, Kim DJ, Yie SW, Lee SY, and Hwang SB: Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2. Virus Res 2001, 74:89-98.
26. Matsumoto M, Hsieh TY, Zhu N, VanArsdale T, Hwang SB, Jeng KS, Gorbalenya AE, Lo SY, Ou JH, Ware CF, and Lai MM: Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. Journal of Virology 1997, 71:1301-9.
27. Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Faure G, Crainic R, and Budkowska A: Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol 2001, 75:8240-50.
28. Widell A, Molnegren V, Pieksma F, Calmann M, Peterson J, and Lee SR: Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase. Transfus Med 2002, 12:107-13.
29. Sabile A, Perlemuter G, Bono F, Kohara K, Demaugre F, Kohara M, Matsuura Y, Miyamura T, Brechot C, and Barba G: Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 1999, 30:1064-76.
30. Yao ZQ, Ray S, Eisen-Vandervelde A, Waggoner S, and Hahn YS: Hepatitis C virus: immunosuppression by complement regulatory pathway. Viral Immunol 2001, 14:277-95.
31. Erhardt A, Hassan M, Heintges T, and Haussinger D: Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology 2002, 292:272-84.
32. Shrivastava A, Manna SK, Ray R, and Aggarwal BB: Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. Journal of Virology 1998, 72:9722-8.
33. Balasubramanian A, Ganju RK, and Groopman JE: Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem 2003, 278:35755-66.
34. Kadoya H, Nagano-Fujii M, Deng L, Nakazono N, and Hotta H: Nonstructural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter. Microbiol Immunol 2005, 49:265-73.
35. Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, Barber GN, Levy DE, Mukaida N, and Gretch DR: Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 2001, 75:6095-106.
36. Yoshida H, Kato N, Shiratori Y, Otsuka M, Maeda S, Kato J, and Omata M: Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J Biol Chem 2001, 276:16399-405.
37. Xiao S, Xu C, and Jarvis JN: C1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms: evidence that the 126 kD phagocytic C1q receptor mediates immune complex activation of HUVEC. Clin Exp Immunol 2001, 125:360-7.
38. Gibson PG, Simpson JL, and Saltos N: Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001, 119:1329-36.
39. Fujimura M, Myou S, Nomura M, Mizuguchi M, Matsuda T, Harada A, Mukaida N, Matsushima K, and Nonomura A: Interleukin-8 inhalation directly provokes bronchoconstriction in guinea pigs. Allergy 1999, 54:386-91.